A Novel Phosphoglucomutase-3 Gene Variant Causing Milder Phenotype in Two Families
Journal of Clinical Immunology · 29.03.2026 · 46 (1)
DOI: 10.1007/s10875-026-02012-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Immunology, online erschienen am 29.03.2026. Verfasst von Betul Gemici Karaaslan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Immunology and Allergy, School of Medicine, Istanbul University-Cerrahpaşa, Kocamustafapasa, Fatih Istanbul, 34098, Türkiye. Hauptthemen laut MEDLINE: Phosphoglucomutase, Phenotype, Mutation, Genetic Predisposition to Disease. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul University Cerrahpaşa.
Abstract (Originalsprache)
Background
Phosphoglucomutase 3 deficiency (PGM3 deficiency) is a rare congenital disorder of glycosylation classically associated with severe immunodeficiency, skeletal abnormalities, and neurodevelopmental impairment. However, emerging evidence suggests that PGM3 deficiency may also present with attenuated or milder clinical phenotypes. In this study, we describe patients with a novel PGM3 variant exhibiting a less severe immunological and clinical presentation, thereby expanding the known phenotypic spectrum of PGM3 deficiency.
Methods
Demographic-data and Wechsler Intelligence Scale for Children profiles were evaluated alongside laboratory data, including complete blood cell counts, lymphocyte subsets, serum immunoglobulin levels, vaccine antibody titers, and lymphocyte cytokine profiles. Whole exome sequencing was conducted, and phospho-flow assays were utilized for the analysis of p-STATs.
Results
Five patients with a mild form of PGM3 deficiency were described, exhibiting a Hyper-IgE Syndrome phenotype without severe skeletal dysplasia or dysmorphism, with the exception of one patient displaying very mild skeletal dysplasia and three patients exhibiting mild to moderate intellectual disability. All patients demonstrated an increase in Natural Killer T cells and a decrease in B cells, alongside an increase in activated CD4 + T cells (CD45RO+), a decrease in naïve CD4 + and CD8 + T cells (CD45RA+ CCR7+), and an increase in TEMRA CD8 + T cells (CD45RA+CCR7–). Functional analysis of all patients revealed impaired PGM3 function, as evidenced by decreased surface expression of gp130 and p-STAT3.
Conclusion
Defective glycosylation in PGM3 deficiency leads to reduced gp130 expression and attenuated gp130-dependent STAT3 phosphorylation. The resulting cellular features partially overlap with those observed in STAT3 loss-of-function and gp130 deficiency, supporting a shared signaling mechanism while remaining clinically distinct.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Immunology and Allergy, School of Medicine, Istanbul University-Cerrahpaşa, Kocamustafapasa, Fatih Istanbul, 34098, Türkiye.
- Division of Immunology, Boston Children's Hospital, Boston, MA, USA.
- Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
- Institute of Regenerative Medicine and Biotherapy, INSERM, University of Montpellier, Montpellier, France.
- Department of Pediatric Immunology and Allergy, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye.
- Department of Medical Genetics, Istanbul University Faculty of Medicine, Istanbul, Türkiye.
Förderung
- Istanbul University Cerrahpaşa
Zitieren
APA
Gemici Karaaslan, B., Benamar, M., Ulas, S., Aydemir, S., Yesil, G., Gezdirici, A., Sari, A. A., Nepesov, S., Cokugras, H., Camcioglu, Y., Ayaz, A., Aydogmus, C., Charbonnier, L. M., Chatila, T., & Kiykim, A. (2026). A Novel Phosphoglucomutase-3 Gene Variant Causing Milder Phenotype in Two Families. Journal of Clinical Immunology, 46(1). https://doi.org/10.1007/s10875-026-02012-2
Vancouver
Gemici Karaaslan B, Benamar M, Ulas S, Aydemir S, Yesil G, Gezdirici A, et al. A Novel Phosphoglucomutase-3 Gene Variant Causing Milder Phenotype in Two Families. Journal of Clinical Immunology. 2026;46(1). doi:10.1007/s10875-026-02012-2
BibTeX
@article{GemiciKaraaslan2026,
author = {Gemici Karaaslan, Betul and Benamar, Mehdi and Ulas, Selami and Aydemir, Sezin and Yesil, Gozde and Gezdirici, Alper and Sari, Aysun Ayaz and Nepesov, Serdar and Cokugras, Haluk and Camcioglu, Yildiz and Ayaz, Akif and Aydogmus, Cigdem and Charbonnier, Louis-Marie and Chatila, Talal and Kiykim, Ayca},
title = {A Novel Phosphoglucomutase-3 Gene Variant Causing Milder Phenotype in Two Families},
journal = {Journal of Clinical Immunology},
year = {2026},
volume = {46},
number = {1},
doi = {10.1007/s10875-026-02012-2}
}
EUVIMED